| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.2M | +92.6% | -5.0% |
| Cost of Revenue | $31.1M | +96.3% | -0.7% |
| Gross Profit | $26.1M | +88.3% | -9.7% |
| R&D Expense | $1.2M | -37.5% | -34.5% |
| SG&A Expense | $8.5M | +3.1% | -6.1% |
| Operating Income | $2.1M | +130.7% | -31.9% |
| Pre-tax Income | $2.1M | +130.6% | -33.6% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | $2.1M | +130.4% | -33.3% |
| EPS (Basic) | $0.16 | +129.6% | -33.3% |
| EPS (Diluted) | $0.16 | +129.6% | -33.3% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | -82.5% | -78.1% |
| Accounts Receivable | $40.3M | +85.3% | -6.8% |
| Inventory | $124.0M | -1.4% | +11.1% |
| Current Assets | $171.3M | +0.9% | -1.7% |
| Total Assets | $240.9M | -0.4% | -5.2% |
| Current Liabilities | $38.9M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.0M | -788.5% | — |
| Capital Expenditures | $1.1M | +256.3% | — |
| Investing Cash Flow | -$1.4M | -266.5% | — |
| Financing Cash Flow | -$4.0M | -10.1% | — |
| Free Cash Flow | -$16.1M | -708.2% | — |
| -8.8% |
| Total Liabilities | $70.5M | -4.8% | -6.3% |
| Stockholders' Equity | $170.4M | +1.5% | -4.7% |